Canada Markets closed

Hansoh Pharmaceutical Group Company Limited (3KY.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.59000.0000 (0.00%)
At close: 09:15AM CET
Full screen
Previous Close1.5900
Bid1.5900 x N/A
Ask1.7300 x N/A
Day's Range1.5900 - 1.5900
52 Week Range1.4000 - 2.1600
Avg. Volume32
Market Cap10.25B
Beta (5Y Monthly)0.59
PE Ratio (TTM)28.39
EPS (TTM)0.0560
Earnings DateN/A
Forward Dividend & Yield0.02 (1.00%)
Ex-Dividend DateSept 08, 2022
1y Target EstN/A
  • Business Wire

    KiOmed Pharma and Hansoh Pharma Announce License Agreement for KiOmedinevsOne in China’s Mainland, Macau and Taiwan

    HERSTAL, Belgium & SHANGHAI, September 26, 2022--KiOmed Pharma, a Belgian biotechnology company with a focus on the development, manufacture and distribution of safe and effective medical devices based on a medical-grade highly pure natural chitosan-derivative, and Hansoh Pharmaceutical Group Company Limited (SEHK: 3692), a leading biopharmaceutical company in Asia, today announced a license agreement for the development and commercialization of KiOmedinevsOne, a carboxymethyl chitosan injection